Stoke Therapeutics
Latest round
- Series B
Last raised
- Oct 2018
Total raised
- $130M
Investors
- 9
About Stoke Therapeutics
Stoke Therapeutics, Inc. specializes in RNA-based therapies, focusing on enhancing gene expression to treat genetic disorders caused by haploinsufficiencies.Founded in 2014 and headquartered in Bedford, US, Stoke Therapeutics develops RNA-based therapies targeting genetic diseases.04 mn.Stoke Therapeutics focuses on innovative RNA-based therapies, utilizing its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) platform. This platform is engineered to enhance protein production from genes that are partially dysfunctional, targeting genetic diseases like Dravet syndrome. Their flagship product, zorevunersen (STK-001), is under clinical evaluation with potential applications extending to conditions such as autosomal dominant optic atrophy (ADOA).20 mn.Stoke Therapeutics aims to launch new products leveraging its TANGO platform, with ongoing clinical trials for zorevunersen (STK-001) poised to address Dravet syndrome and potentially other genetic disorders. The company plans to expand its market presence in North America and Europe, seeking to enhance partnerships and licensing agreements by 2024.5 mn from November 2020 will be directed towards advancing their clinical trials and supporting the development of new therapeutic solutions.
Who invested in Stoke Therapeutics
9 investors across 2 rounds
See all investors in Stoke Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Stoke Therapeutics
Who invested in Stoke Therapeutics?
Stoke Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stoke Therapeutics raised?
Stoke Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Stoke Therapeutics last raise money?
Stoke Therapeutics's most recent round on record is a Series B, in Oct 2018.
What does Stoke Therapeutics do?
Stoke Therapeutics is a biotechnology company.
Where is Stoke Therapeutics headquartered?
Stoke Therapeutics is headquartered in Bedford, US.
Which VCs invest in companies like Stoke Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Stoke Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Stoke Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.